NO920984L - Fremgangsmaate for diastereoselektiv reduktiv pinakol-kobling av homokirale alfa-aminoaldehyder - Google Patents

Fremgangsmaate for diastereoselektiv reduktiv pinakol-kobling av homokirale alfa-aminoaldehyder

Info

Publication number
NO920984L
NO920984L NO92920984A NO920984A NO920984L NO 920984 L NO920984 L NO 920984L NO 92920984 A NO92920984 A NO 92920984A NO 920984 A NO920984 A NO 920984A NO 920984 L NO920984 L NO 920984L
Authority
NO
Norway
Prior art keywords
hyders
homociral
aminoal
alfa
procedure
Prior art date
Application number
NO92920984A
Other languages
English (en)
Norwegian (no)
Other versions
NO920984D0 (no
Inventor
Joachim-Heiner Jendralla
Detlef Jacobi
Bernhard Kammermeier
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4122911A external-priority patent/DE4122911A1/de
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO920984D0 publication Critical patent/NO920984D0/no
Publication of NO920984L publication Critical patent/NO920984L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C269/06—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups by reactions not involving the formation of carbamate groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/20—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C07D217/16—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrrole Compounds (AREA)
  • Indole Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Lubricants (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
NO92920984A 1991-03-15 1992-03-13 Fremgangsmaate for diastereoselektiv reduktiv pinakol-kobling av homokirale alfa-aminoaldehyder NO920984L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4108357 1991-03-15
DE4122911A DE4122911A1 (de) 1991-07-11 1991-07-11 Verfahren zur diastereoselektiven reduktiven pinakol-kupplung von homochiralen (alpha)-aminoaldehyden

Publications (2)

Publication Number Publication Date
NO920984D0 NO920984D0 (no) 1992-03-13
NO920984L true NO920984L (no) 1992-09-16

Family

ID=25901877

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92920984A NO920984L (no) 1991-03-15 1992-03-13 Fremgangsmaate for diastereoselektiv reduktiv pinakol-kobling av homokirale alfa-aminoaldehyder

Country Status (16)

Country Link
US (1) US5519113A (fi)
EP (1) EP0503561B1 (fi)
JP (1) JP3254238B2 (fi)
KR (1) KR920018013A (fi)
AT (1) ATE172713T1 (fi)
AU (1) AU664696B2 (fi)
CA (1) CA2063013A1 (fi)
CS (1) CS76792A3 (fi)
DE (1) DE59209540D1 (fi)
DK (1) DK0503561T3 (fi)
ES (1) ES2124710T3 (fi)
FI (1) FI921069A (fi)
HU (1) HUT62851A (fi)
IE (1) IE920828A1 (fi)
MX (1) MX9201116A (fi)
NO (1) NO920984L (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5362912A (en) * 1989-05-23 1994-11-08 Abbott Laboratories Process for the preparation of a substituted diaminodiol
EP1064298B1 (en) 1998-03-19 2008-10-08 Vertex Pharmaceuticals Incorporated Inhibitors of caspases
PE20011350A1 (es) 2000-05-19 2002-01-15 Vertex Pharma PROFARMACO DE UN INHIBIDOR DE ENZIMA CONVERTIDORA DE INTERLEUCINA-1ß (ICE)
AU2003211052A1 (en) * 2002-02-11 2003-09-04 Vertex Pharmaceuticals Incorporated Phospholipids as caspase inhibitor prodrugs
CN1980658A (zh) * 2004-05-27 2007-06-13 沃泰克斯药物股份有限公司 治疗自身炎性疾病的ice抑制剂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5142056A (en) * 1989-05-23 1992-08-25 Abbott Laboratories Retroviral protease inhibiting compounds
HUT64738A (en) * 1990-06-01 1994-02-28 Du Pont Merck Pharma Process for preparing 1,4-diamino-2,3-dihydroxi-butane compounds and pharmaceutical compositions contianing them
AU8205491A (en) * 1990-06-01 1991-12-31 Du Pont Merck Pharmaceutical Company, The 1,4-diamino-2,3-dihydroxybutanes

Also Published As

Publication number Publication date
CS76792A3 (en) 1992-10-14
ATE172713T1 (de) 1998-11-15
HU9200864D0 (en) 1992-05-28
FI921069A (fi) 1992-09-16
KR920018013A (ko) 1992-10-21
AU1284092A (en) 1992-09-17
AU664696B2 (en) 1995-11-30
JP3254238B2 (ja) 2002-02-04
DE59209540D1 (de) 1998-12-03
EP0503561A2 (de) 1992-09-16
EP0503561A3 (en) 1993-05-05
HUT62851A (en) 1993-06-28
CA2063013A1 (en) 1992-09-16
FI921069A0 (fi) 1992-03-12
ES2124710T3 (es) 1999-02-16
NO920984D0 (no) 1992-03-13
JPH0578290A (ja) 1993-03-30
US5519113A (en) 1996-05-21
IE920828A1 (en) 1992-09-23
EP0503561B1 (de) 1998-10-28
DK0503561T3 (da) 1999-07-05
MX9201116A (es) 1992-10-01

Similar Documents

Publication Publication Date Title
CA2064634A1 (en) 9-deoxo-8a-aza-8a-homoerythromycin a derivatives modified at the 4"- and8a-positions
TW283642B (fi)
AU7095587A (en) 1,4-diazepines
NO923879L (no) Fremgangsmaate for diastereoselektiv reduktiv pinakol-kobling av homochirale alfa-aminoaldehyder
NO973580D0 (no) Fremgangsmåte for fremstilling av mono-N-substituerte tetraazamakrosykliske forbindelser
NO920984L (no) Fremgangsmaate for diastereoselektiv reduktiv pinakol-kobling av homokirale alfa-aminoaldehyder
TW198022B (fi)
DK0424156T3 (da) Behandling af hepatobiliær sygdom med 15-ketoprostaglandinforbindelser
SE8203580L (sv) Sett att framstella apovinkaminsyraestrar
FI892681A0 (fi) Nya jodade icke-joniska trijodbenzenfoereningar och dessa innehaollande kontrastmedel.
DK0623620T3 (da) 5-HT3-pyrrolopyrazinderivater
AU639322B2 (en) Biochemical treatment with 15-dehydroxy-16-oxoprostaglandin compounds
NO892410L (no) Fremgangsmaate for fremstilling av (+) 1-((3,4,5-trimethoxy)-benzyloxymethyl)-1-fenyl-n,n-dimethyl-n-propylamin.
DE58909089D1 (de) Verwendung von Myricetin-3-0-beta-D-glucuronid als Arzneimittel.
AU553351B2 (en) Organophosphate derivatives